The CCL2/CCR2 chemokine axis is implicated in TAM infiltration, and the inhibition of CCL2 led to lower TAM recruitment and improved ICI efficacy in a mouse model of GBM [145,146]. The gene discussed is CCR2; the disease is glioblastoma.